## Abstract A new formulation of a sublingual tablet with 10 mg apomorphine was examined in 13 patients with Parkinson's disease. Vitamin C (250 mg) was added sublingually to lower the salivary pH. Four patients received sublingual apomorphine and nine received sublingual apomorphine as well as vit
A New Type (I) of Prodrug of Catecholamines: An Opportunity to Improve the Treatment of Parkinson′s Disease.
✍ Scribed by Bastiaan J. Venhuis; Haakan V. Wikstroem; Nienke Rodenhuis; Staffan Sundell; Durk Dijkstra
- Publisher
- John Wiley and Sons
- Year
- 2010
- Weight
- 26 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Parkinsonism has been described in patients with Gaucher's disease (GD). We reviewed the 10 cases of patients with both parkinsonism and GD recorded in the French national GD registry, as well as 49 previously published cases. Relative to the general population, parkinsonism in GD patie
complementary procedure for surveillance colonoscopy in patients with the latter disease. Recently, fluorescence endoscopy with 5-aminolaevulinic acid (5-ALA) sensitization has been shown to be a promising procedure for the detection of dysplasia in patients with UC. By this procedure, dysplastic l
## Abstract Five parkinsonian subjects with chronic bilateral stimulation of the subthalamic nucleus and five sex‐ and age‐matched healthy controls grasped, lifted, and held an instrumented object. The grip–lift task was either performed at self‐determined speed or in response to an auditory cuing
Gait disturbances are among the primary symptoms of Parkinson's disease (PD) and contribute significantly to a patient's loss of function and independence. Standard treatment includes antiparkinsonian drugs, primarily levodopa. In addition to the standard drug regime, physical therapy is often presc